Two Escherichia coli strains isolated from urinary tract infections were resistant to streptomycin, kanamycin, neomycin, tetracycline and sulphonamides. The strains also produced colicins B and M. The resistance to streptomycin, kanamycin and neomycin and the ability to produce colicins B and M could be transferred to an E. coli K12 recipient. Resistance and colicinogeny markers were transferred together by conjugation, and did not segregate even after interrupted mating or phage P1 -mediated transduction. Hence, the drug-resistance and colicinogeny markers were carried by the same plasmid, designated as R . ColBM plasmid.
INTRODUCTION
F-like plasmids of the Enterobacteriaceae (Meynell et al., 1968) are classified into five incompatibility groups (Datta, 1975; Novick et al., 1976) . A sixth group was proposed recently by Monti-Bragadin et al. (1975) . The distribution of the F-like plasmids among these groups is not uniform; most of the plasmids belong to the IncFII and IncFI groups (Dennison, 1972; Hedges et al., 1973; Datta, 1975) . The IncFIII, IncFIV and IncFV groups are each represented by only a few plasmids (Hedges & Datta, 1972; Datta, 1975; De La Cruz et al., 1979) . Until recently, only three plasmids were known in the IncFIII incompatibility group, namely ColBM-K98 (Frydman & Meynell, 1969) , Hly-20-72 and MIP240 (Le Minor & Le Coueffic, 1975; Le Minor et al., 1976) , and none of these carried drugresistance markers.
During a search for R plasmids in Escherichia coli strains isolated from urinary tract infections, several R . ColBM plasmids were identified. Incompatibility studies showed that these plasmids belonged to the IncFIII group. As they were the first R plasmids identified in this incompatibility group, the biological and molecular properties of two of them were studied extensively. The results are reported here.
Transfer of resistance. For the transfer of resistance, 0.1 ml of an exponential phase culture of the donor and 0.1 ml of an overnight culture of the recipient were mixed with 5 ml BHI broth and incubated for 48 h at 37 "C. Simmons citrate agar containing the required growth factors (40 pg ml-l) and antibiotics (25 pg ml-1) was used for selection. When resistance was transferred from wild-type donors, the counter-selected marker was nalidixic acid sensitivity. Transconjugants were re-isolated twice on the selection medium.
Transduction. Phage P1-mediated transduction was performed as described by Lennox (1955) . Fi character. Fi character was determined as previously described (Sonea et al., 1971) . Plasmids were in an Hfr host (SAS241) and the recipient strain for the transfer of chromosomal markers was W677-Azi,Sm. Selection was for Thrf Leu+.
Type ofpilus. The type of donor pilus was determined as described by Meynell & Datta (1966) . Plasmids were in E. coli C600 and the second host used to obtain an HFT (high frequency of transfer; Meynell & Datta, 1966) population was strain J53. The donor-specific phage was the RNA phage f2.
Plasmid incompatibility. For incompatibility studies, 1 ml of an exponential phase culture of the donor and 1 ml of an overnight culture of the recipient were mixed with 2 ml BHI broth and incubated for 1 h at 37 "C. In the first series of experiments, selection was made for the donor plasmid only. The transconjugants were re-isolated twice on the selection medium. This technique produced a 100 % elimination of the recipient plasmid when incompatible control plasmids were used (see Table 3 ). In a second series of experiments, selection was made for both donor and recipient plasmid markers. To determine the stability of clones carrying both plasmids, 10 to 18 transconjugants from each transfer were subcultured ten times in antibioticfree BHI (size of the inoculum The incubation period was generally short in order to reduce the probability of re-infection. At the end of the experiment at least 25 colonies per transconjugant were analysed for the presence of markers from the two plasmids.
Plasmid DNA isolation. Plasmid DNA was isolated by the method of Humphreys et al. (1975) from cleared lysates obtained by the method of Clewell & Helinski (1969) . The plasmid DNA was separated by ultracentrifugation (Beckman L2-65B preparative ultracentrifuge, Ti75 rotor, 36000 rev. min-l for 66 h at 20 "C) in a CsCl density gradient (initial density 1.625 g ml-l) in the presence of ethidium bromide (500 pg ml-1). DNA bands were visualized by a long-wave ultraviolet lamp. The polyallomer tubes were punctured just below the covalent closed circular DNA band and the latter was extracted with a syringe. Dialysis was performed as described by Palchaudhuri et al. (1975) . DNA in the extract was precipitated by alcohol and collected by centrifugation at 10000 rev. min-' in the cold. It was redissolved in Tris/EDTA buffer (10 mMTris pH 7.9, 10 mM-NaC1 and 0.1 mM-Na,EDTA) and kept refrigerated.
Agurose g d electrophoresis. Agarose gel electrophoresis of plasmid DNA was performed as described by Meyers et al. (1976) in a vertical slab electrophoresis apparatus (model 220, Bio-Rad) at room temperature. Electrophoresis was carried out at 120 V and 60 mA. Plasmids of known size were applied in the same gel as controls: R1,62 megadaltons (Mdal); RP4,34 Mdal; Sa, 23 Mdal; ColE1,4.2 Mdal (Meyers et al., 1976) . For the coloration of the DNA bands the gel was immersed for 30 min in electrophoresis buffer (Meyers et af., 1976) containing 0.5 pg ethidium bromide ml-l.
Electron microscopy. Samples for electron microscopy were prepared by a modified Kleinschmidt technique (Zollinger et al., 1977 Hfr Cavalli nal pro-22 met-63, Fthr-1 leu-6 thi-1 lacy1 tonA2l supE44 A-, Fthr-1 leu-6 thi-1 lacy1 xyl-7 ara-13 mtI-2 gal-3 tonA2 AR azi rpsL thr-1 leu-6 thi-1 argE3 his-4 proA2 mtl-1 xyI-5 urn-15 galK2 lac YI 
R E S U L T S
Transferability by conjugation. The original plasmid-carrying E. coli strains were isolated from urinary tract infections. They were resistant to streptomycin (Sm), kanamycin (Km), neomycin (Nm), tetracycline (Tc) and sulphonamides (Su) and produced a B-type colicin. The resistance to Sm, Km and Nm, as well as the ability to produce the colicin, could be transferred to derivatives of E. coli K12 (SAS241 and C600) by conjugation. Resistance and colicinogeny markers were always transferred together, even after interrupted mating or P1 -mediated transduction (results not shown).
Identijication of the colicin. Preliminary identification of the colicin produced by the plasmid-carrying strains was based on the results obtained with a colicin B-resistant mutant. The zone of inhibition obtained with this mutant was barely visible compared with the medium-sized zone obtained with the colicin-sensitive indicator strains. Suspecting the presence of a colicin M, which often accompanies colicin B production (Fredericq & Smarda, 1970) , a double mutant, resistant to colicins B and M (185/Ab 3a/T1), was used. As expected, the double mutant was totally insensitive to the colicins produced by the two plasmids. Hence, the two R plasmids carry determinants for colicinogeny B and M. They will be designated collectively as R . ColBM plasmids.
Fi character. The Fi character of the two plasmids was determined in an Hfr donor (SAS241). Both plasmids inhibited the transfer of chromosomal markers to an F-recipient for 2 h at 37 "C. Bacteria were then infected with phage f2 (multiplicity of infection, about 20) and further incubated for a short period to allow phage adsorption. Excess phage was neutralized with f2 antiserum and the mixture was filtered (Millipore membrane, 0.45 pm pore size). The filter was transferred to TYECa and incubated for 1.5 to 2 h at 37 "C. The phage titre was determined in samples taken at the beginning (To) and at the end (Tl) of the incubation period. The increment (I) of the phage titre is given by the formula I=T,/To. When I was determined in a non-HFT population the same method was used except that the second host (strain 553) was omitted. (Meynell et a!., 1968) . Pilusproduction. The results obtained in studies on the type of pilus produced are presented in Table 2 . The production of an F-type pilus by the two R.ColBM plasmids is clearly shown by the net increase in plaque-forming units, particularly when HFT populations were used. Hence, the two plasmids are F-like plasmids, as defined by Meynell et al. (1 968) .
Incompatibility studies. The results of the incompatibility studies with R . ColBM plasmids are presented in Table 3 . The 100% elimination of the MIP240 (IncFIII) plasmid by the R . ColBM plasmids clearly indicates that the latter belong to the IncFIII incompatibility group.
The results obtained with an IncFII plasmid are more difficult to interpret (Table 3 ) since both R . ColBM plasmids give a partial incompatibility reaction with pSAS1205 (IncFII).
This partial incompatibility is not due to a delayed elimination of one of the plasmids, since even after ten subcultures in antibiotic-free medium more than 90 yo of the clones originally selected for the presence of the two plasmids were still carrying both of them ( Table 5 , lines 1 and 2).
The study of the partial incompatibility between R, ColBM and IncFII plasmids in a recA host (Table 4 ) allows easy differentiation between the two R . ColBM plasmids (pSAS 1201 and pSAS1203). In the case of the former, 74.5% of the transconjugants lost the IncFII plasmid when selection was made for pSAS 1201, whereas the reciprocal cross gave only 2 yo elimination of pSAS1201 (Table 4 ). This asymmetrical loss of the TncFII plasmid was also evident when recA transconjugants carrying both plasmids were subcultured in an antibiotic-free medium ( Table 5 , line 3). In the case of plasmid pSAS1203, partial incompatibility between pSAS1203 and the IncFII plasmid (pSAS1205) in a recA host was diminished in both directions (Table 4 , lines 3 and 4) when selection was made for the donor plasmid. However, when transconjugants carrying both plasmids were subcultured in antibiotic-free medium, an asymmetric loss of pSAS1205 was obtained as with pSAS1201 (Table 5 , line 4). Nonetheless, the elimination of IncFII by pSAS1203 was only 3.9%, whereas the elimination of the same plasmid by pSAS1201 was 32.8% (Table 5 , lines 3 and 4).
Molecular studies. The molecular size of the two R . ColBM plasmids was determined by agarose gel electrophoresis and by contour length measurements in the electron microscope. The agarose gel electrophoresis results indicated that both R . ColBM plasmids were about 51 Mdal. Contour length measurements of ten molecules of each R . ColBM plasmid, using plasmid ColEl as internal standard (Fig. l) , showed that both were about 52 Mdal.
DISCUSSTON
There are only a few reports of naturally occurring plasmids which carry resistance and colicinogenic markers on the same molecule (Siccardi, 1966; Fredericq & Delhalle, 1972; Chabbert et al., 1972) and I-like R-plasmids probably represent the exception to the rule (Falkow, 1975) . This is puzzling since the association of the two types of markers might offer a selective advantage to the host. Moreover, it is difficult to understand how Col plasmids can avoid 'contamination' with resistance genes, especially with those carried by transposons (Cohen & Kopecko, 1976; Starlinger & Saedler, 1976) . The same observation is also true for Ent plasmids which only rarely carry resistance genes (Gyles et nl., 1977) . It would therefore seem that recombination between different types of plasmids is less frequent in nature than in laboratory conditions (Fredericq & Delhalle, 1972) .
Study of the incompatibility of the R.ColBM plasmids showed that they belong to the IncFIII incompatibility group. Plasmids belonging to this group were found to give partial incompatibility reactions either with IncFIL plasmids (Finnegan & Willetts, 1972 ;  or with an IncFIV plasmid (Le Minor & Le Coueffic, 1975; De La Cruz et al., 1979) . However, these partial reactions cannot be compared to the strong incompatibility reactions between IncFIII plasmids as observed in the present study (see Table 3 ). Therefore, we consider that IncFIII should be maintained as an independent group rather than as a member of an IncFIII-IncFIV incompatibility complex (De La Cruz et al., 1979) , at least until cloning experiments (Cabello et al., 1976; Timmis et al., 1978; Manis & Kline, 1978) clearly establish the nature of its incompatibility relations.
The mechanism of partial incompatibility is not well understood and the repressor model of incompatibility (Pritchard et al., 1969; Novick, 1969; Uhlin & Nordstrom, 1975; Cabello et al., 1976; Timmis et al., 1978) allows several different interpretations of this phenomenon. Firstly, partial incompatibility might reflect the presence of a less specific effector of incompatibility (i.e. repressor) which reacts with plasmids of different specificities. This also supposes that the operator of an IncFIII plasmid might be recognized by repressors of various specificities. We do not have experimental evidence which could favour such a mechanism.
A second hypothesis may consider partial incompatibility as a particular form of a double incompatibility (Grant & Pittard, 1974; Cabello et al., 1976; Timmis et al., 1978) with one of the repressors being partially defective. The partial defectiveness of one of the repressors could be the direct result of the recombination which originated the composite plasmid. If this hypothesis is correct, and if the conditions which protect lambda repressor from inactivation, such as a recA mutation (Roberts & Roberts, 1975; Roberts et al., 1978) , could also protect a partial defective incompatibility repressor, we should observe the appearance of an asymmetrical loss of one of the plasmids in a recA host. This is because protection of a partially defective repressor might re-establish the conditions of a double incompatibility, characterized by the asymmetrical loss of one of the plasmids (Cabello et al., 1976; Timmis et al., 1978) . Such an asymmetrical loss was indeed observed when incompatibility between R . ColBM and IncFII plasmids was studied in a recA host (see Tables 4   and 5 ). This would suggest that partial incompatibility of R. ColBM and IncFII plasmids might be due to the production of a defective IncFII incompatibility repressor by the R. ColBM plasmids. However, we must be cautious with this interpretation until the protective effect of a r e d mutation on incompatibility repressors is clearly established.
Other interpretations of the partial incompatibility are also possible, such as a divergent evolution of two identical incompatibility determinants (Manis & Kline, 1978) . Finally, it might be possible that several different mechanisms can lead to a partial incompatibility and only cloning experiments will establish the real mechanism in each case. The two R . ColBM plasmids isolated in the present study are the first R plasmids belonging to the IncFIII incompatibility group described so far. The uniqueness of the R . ColBM plasmids makes them ideal epidemiological markers for studying the spread of drugresistant strains in a hospital environment. It is known that the appearance of a drugresistant strain in a patient is more often the result of the spread of hospital strains rather than of an in vivo transfer of an R plasmid (Richmond, 1975; Richmond & Petrocheilou, 1978) . Such a mechanism seems also to be confirmed in the present case, since E. coli strains carrying R.ColBM plasmids were isolated from two other patients in the same hospital (unpublished results).
The isolation of the first IncFIII plasmids carrying resistance genes is also important for incompatibility studies. The other known plasmids in this group (Frydman & Meynell, 1969; Le Minor & Le Coueffic, 1975; Le Minor et al., 1976 ) cannot be selected for easily and can be used mainly as recipient plasmids. This makes the study of incompatibility difficult, particularly with other plasmids that also cannot be selected for. The newly isolated R.ColBM IncFIII plasmids do not have this disadvantage and can be used in incompatibility studies as either donor or recipient plasmids.
